PHILADELPHIA – Two doctors and a physician's assistant have been criminally charged in connection with an alleged "pill mill" conspiracy that involved unlawfully distributing Schedule II controlled substances through a voicemail refill line, the U.S. Attorney's Office announced today. Dr. Joseph P. DiRenzo Jr., 64, of Egg Harbor Township, New Jersey, Dr. Marc A. Matozzo, 56, of Woodbury, New Jersey, and Joseph D. Norris, P.A., 62, of Philadelphia, Pennsylvania, face charges including conspiracy to unlawfully distribute controlled substances.

The indictment alleges that from January 2020 through March 2025, the defendants operated a system allowing patients to request and receive refills of oxycodone and amphetamine prescriptions without direct interaction with a licensed prescriber. DiRenzo and Matozzo are each charged with two counts of unlawful distribution of controlled substances, while Norris faces two counts of unlawful distribution and one count of false statements related to health care matters.

Despite receiving warnings from pharmacy benefit managers and insurers about dangerous prescribing practices, including excessive amounts and combinations of controlled substances, the defendants allegedly continued their operation. The indictment further claims that some patients who used the refill line suffered drug overdoses and died, yet the defendants persisted in prescribing without patient interaction.

U.S. Attorney David Metcalf emphasized the severity of the charges, saying, “Medical professionals who prescribe powerful drugs indiscriminately are fueling the opioid crisis that continues to grip our area. Just like street dealers, they are perpetuating people’s pain and addiction.” Wayne A. Jacobs, Special Agent in Charge of FBI Philadelphia, added, “The defendants in this case allegedly violated that trust and their professional oaths by continuing to prescribe dangerous quantities of Schedule II narcotics, even after being warned about the risks posed by their prescribing practices.”

These charges are part of the Department of Justice’s 2026 National Health Care Fraud Takedown, a nationwide enforcement action that has resulted in charges against 455 defendants, including 90 medical professionals, for alleged health care fraud and opioid abuse schemes totaling over $6.5 billion in false claims. The Department of Justice, through its newly created National Fraud Enforcement Division, remains focused on combating fraud against the American people.